CRBN and Miyoshi myopathy: Notably, some relapsed MM patients maintain CRBN expression and IKZF1 degradation but progress, implying potential underestimation of CRBN-independent mechanisms such as IL-6/STAT3 pathway activation (Teoh et al., 2025).